These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1667342)

  • 41. The use of high-performance size exclusion chromatography (HPSEC) as a molecular weight screening technique for polygalacturonic acid for use in pharmaceutical applications.
    White GW; Katona T; Zodda JP
    J Pharm Biomed Anal; 1999 Sep; 20(6):905-12. PubMed ID: 10746959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Size-exclusion chromatographic determination of polymer molar mass averages using a fractal calibration.
    García-Lopera R; Codoñer A; Bañó MC; Abad C; Campos A
    J Chromatogr Sci; 2005; 43(5):226-34. PubMed ID: 15975240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A broad-standard technique for correcting for band broadening in size-exclusion chromatography.
    Zhang P; Mazoyer P; Gilbert RG
    J Chromatogr A; 2016 Apr; 1443():267-71. PubMed ID: 27016112
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A rapid and accurate method for the quantitative estimation of natural polysaccharides and their fractions using high performance size exclusion chromatography coupled with multi-angle laser light scattering and refractive index detector.
    Cheong KL; Wu DT; Zhao J; Li SP
    J Chromatogr A; 2015 Jun; 1400():98-106. PubMed ID: 25990349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative LC-MS of polymers: determining accurate molecular weight distributions by combined size exclusion chromatography and electrospray mass spectrometry with maximum entropy data processing.
    Gruendling T; Guilhaus M; Barner-Kowollik C
    Anal Chem; 2008 Sep; 80(18):6915-27. PubMed ID: 18690749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of branched ultrahigh molar mass polymers by asymmetrical flow field-flow fractionation and size exclusion chromatography.
    Otte T; Pasch H; Macko T; Brüll R; Stadler FJ; Kaschta J; Becker F; Buback M
    J Chromatogr A; 2011 Jul; 1218(27):4257-67. PubMed ID: 21238968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On-line size-exclusion chromatography/mass spectrometry of low molecular mass heparin.
    Henriksen J; Ringborg LH; Roepstorrf P
    J Mass Spectrom; 2004 Nov; 39(11):1305-12. PubMed ID: 15532070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular weight distribution characterization of reactive higher ethyleneamines using size-exclusion chromatography with conventional calibration.
    Eghbali H; Hagen H; Van Engelen M; Meertens W; Schweizer-Theobaldt A; Meunier D
    J Chromatogr A; 2019 Oct; 1603():141-149. PubMed ID: 31277951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural analysis of low molecular weight heparin by ultraperformance size exclusion chromatography/time of flight mass spectrometry and capillary zone electrophoresis.
    Zhang Q; Chen X; Zhu Z; Zhan X; Wu Y; Song L; Kang J
    Anal Chem; 2013 Feb; 85(3):1819-27. PubMed ID: 23273485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Online reverse phase-high-performance liquid chromatography-fluorescence detection-electrospray ionization-mass spectrometry separation and characterization of heparan sulfate, heparin, and low-molecular weight-heparin disaccharides derivatized with 2-aminoacridone.
    Galeotti F; Volpi N
    Anal Chem; 2011 Sep; 83(17):6770-7. PubMed ID: 21780812
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Collaborative study to establish the Low-molecular-mass heparin for assay--European Pharmacopoeia Biological Reference Preparation.
    Gray E; Rigsby P; Behr-Gross ME
    Pharmeuropa Bio; 2004 Dec; 2004(1):59-76. PubMed ID: 15659286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production method affects the pharmacokinetic and ex vivo biological properties of low molecular weight heparins.
    Brieger D; Dawes J
    Thromb Haemost; 1997 Feb; 77(2):317-22. PubMed ID: 9157589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Critical Quality Control Methods for a Novel Anticoagulant Candidate LFG-Na by HPSEC-MALLS-RID and Bioactivity Assays.
    Zheng S; Wang Y; Wu J; Wang S; Wei H; Zhang Y; Zhou J; Shi Y
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Size exclusion chromatography of lignin: The mechanistic aspects and elimination of undesired secondary interactions.
    Andrianova AA; Yeudakimenka NA; Lilak SL; Kozliak EI; Ugrinov A; Sibi MP; Kubátová A
    J Chromatogr A; 2018 Jan; 1534():101-110. PubMed ID: 29292081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of ionic strength and organic modifier concentrations on characterization of aquatic fulvic and humic acids by high-performance size-exclusion chromatography.
    Hoque E; Wolf M; Teichmann G; Peller E; Schimmack W; Buckau G
    J Chromatogr A; 2003 Oct; 1017(1-2):97-105. PubMed ID: 14584694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular mass determination of plasma-derived glycoproteins by ultraviolet matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with internal calibration.
    Belgacem O; Buchacher A; Pock K; Josic D; Sutton C; Rizzi A; Allmaier G
    J Mass Spectrom; 2002 Nov; 37(11):1118-30. PubMed ID: 12447888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multielement characterization of metal-humic substances complexation by size exclusion chromatography, asymmetrical flow field-flow fractionation, ultrafiltration and inductively coupled plasma-mass spectrometry detection: a comparative approach.
    Bolea E; Gorriz MP; Bouby M; Laborda F; Castillo JR; Geckeis H
    J Chromatogr A; 2006 Oct; 1129(2):236-46. PubMed ID: 16859692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and validation of a simple and sensitive size-exclusion chromatography method for quantitative determination of heparin in pharmaceuticals.
    Matanović MR; Grabnar I; Grabnar PA; Roškar R
    Acta Pharm; 2015 Mar; 65(1):43-52. PubMed ID: 25781703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4).
    Padilla A; Gray E; Pepper DS; Barrowcliffe TW
    Br J Haematol; 1992 Oct; 82(2):406-13. PubMed ID: 1329921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of molecular mass values of chondroitin sulfates by fluorophore-assisted carbohydrate electrophoresis (FACE).
    Buzzega D; Maccari F; Volpi N
    J Pharm Biomed Anal; 2010 Mar; 51(4):969-72. PubMed ID: 19931355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.